The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Image in cardiology

Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position

EuroIntervention 2014;10:269 . DOI: 10.4244/EIJV10I2A43

Department of Cardiology, Bichat-Claude-Bernard Hospital, Assistance Publique - Hôpitaux de Paris, Université Paris VII, Paris, France
A 44-year-old man had twice undergone tricuspid valve replacement for endocarditis, using a mitral homograft and a 30 mm tricuspid Carpentier-Edwards Classic annuloplasty ring (Edwards Lifesciences, Irvine, CA, USA) (Figure 1A, Figure 1B) during the last operation in 2001. Endocarditis recurrences resulted in massive tricuspid regurgitation (TR), (Figure 1C, Figure 1D; Moving image 1, Moving image 2) with progressive right-sided heart failure and dyspnoea. Due to the high risk of further surgery, transfemoral tricuspid valve-in-ring implantation of a 26 mm Edwards SAPIEN XT® (Edwards Lifesciences) valve was performed (Figure 1E-Figure 1I; Moving image 3). There was a moderate residual paravalvular leak (Figure 1J, Figure 1K; Moving ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation